Leeford Healthcare has onboarded actors Anushka Sen and Taaruk Raina as brand ambassadors for its skincare brand Alite, as it looks to strengthen its positioning among Gen Z consumers and scale its presence in India’s fast-growing anti-acne segment.
The endorsement-led push comes as the company accelerates its transition from a largely pharma-led portfolio to a more consumer-facing play in science-backed skincare, a category witnessing rising demand for efficacy-driven yet affordable products.
India’s anti-acne cosmetics market, estimated at USD 357.5 million in 2024, is projected to reach USD 700.1 million by 2030, growing at a CAGR of 12.4%, according to Grand View Research. Industry insights suggest acne remains the leading skincare concern among younger consumers, making it a high-growth and high-engagement segment.
Leeford’s latest move reflects a broader strategy to combine its pharmaceutical credibility with sharper brand-building initiatives aimed at younger audiences. The company plans to roll out a 360 degree campaign for Alite, anchored by the two ambassadors, focusing on themes of confidence, individuality and real skin experiences.
“Consumers today are increasingly seeking transparency, efficacy and value in skincare,” said Amit Gupta, Founder and Managing Director, Leeford Healthcare. “Our association with Anushka Sen and Taaruk Raina is aimed at building stronger resonance with young consumers while reinforcing the science-led positioning of Alite.”
The partnership also highlights the growing role of influencer-led communication in driving both awareness and conversion in skincare, particularly among Gen Z consumers who rely heavily on digital content and peer validation in purchase decisions.
Anushka Sen said the association aligns with evolving consumer expectations. “Young consumers today are looking for solutions that address the root cause of concerns rather than temporary fixes,” she said.
Taaruk Raina added, “There is increasing awareness around skincare and its impact on confidence. Brands that combine science with accessibility are likely to see stronger traction.”
Alite’s product portfolio includes anti-acne face washes, gels and spot reduction solutions, developed with dermatology-inspired actives and tailored for Indian skin types and conditions.
The brand is already available across more than 1.2 million retail touchpoints through Leeford’s pharmaceutical distribution network, as well as on e-commerce and quick-commerce platforms.
With increased investments in marketing and brand building, Leeford is targeting a 10–15% share of India’s anti-acne skincare market over the next two years.
